Piper Jaffray Maintains Overweight on Globus Medical, Raises Price Target to $65

Piper Jaffray maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $62 to $65.

Benzinga · 11/07/2019 15:23

Piper Jaffray maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $62 to $65.